Agilent and FAPESP fund life-science research projects in Brazil

Agilent Technologies Inc. and FAPESP, the São Paulo Research Foundation, recently announced the selection of two jointly funded research projects

SANTA CLARA, Calif.—Agilent Technologies Inc. and FAPESP,the São Paulo Research Foundation, recently announced the selection of twojointly funded research projects. FAPESP, the principal funding agency foracademic research in the State of São Paulo, and Agilent are working togetherthrough the Partnership for Technological Innovation to further multinationalcollaboration and promote academic research in São Paulo, Brazil.
The two projects, approved following a joint call forsubmissions, will provide financial support to advance instrumentation andmeasurement techniques related to metabolomics in plant microbiology, massspectrometry and bioenergy. Launched in October 2011, the call for submissionsaims to identify, select and support world-class research projects to createknowledge and communicate results in the international scientific community.This will be done through close technical collaboration between leading facultymembers in the State of São Paulo and Agilent researchers.
One of the approved projects will involve the systematicstudy of the metabolites resulting from cellular processes under specificenvironmental and physiological conditions, specifically a study of thephysiological response of eucalyptus in the presence of high CO2 concentrationsand temperature variations.
The second study will identify volatile compounds producedby Brazilian cyanobacteria and explore their effects on other organisms in theecosystem.
"Agilent's partnership with FAPESP underscores ourcommitment to multinational research and to Brazil, a strategic growth area forus," said Mike McMullen, president of Agilent's Chemical Analysis Group, in astatement. "We look forward to our collaboration with leading researchers atthe University of São Paulo and State University of Campinas and the resultingadvances in fundamental understanding of important plants and microbesindigenous to Brazil."
Approved projects will run for up to 36 months. 

Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

November 2022 Issue Front Cover

Latest Issue  

• Volume 18 • Issue 11 • November 2022

November 2022

November 2022